The first generation of GLP-1 analogs to be developed were short-acting, typically necessitating twice-daily injection (e.g., exenatide)
Combination treatments such as Qsymia or the generic phentermine plus topiramate regimen offer a customizable, cost-effective approach for patients who require more nuanced appetite and craving control
Even at lower doses, GLP-1s carry risks of gastrointestinal issues, including nausea, constipation, and general abdominal discomfort
Wintergerst ES, Maggini S, Hornig DH
This medication should not be used in children under the age of 18 years
GLP-1s can make it easier to eat less, but they can also make it easier to accidentally fall short on protein if youre not intentional